|
|
|
|
|
|
|
| Bronchopneumonia | ||
| Etiology • Variety of aspirated organisms. • Organism dependent on whether community acquired in previously healthy patient (more likely Streptococcus) or • Community acquired in patient with depressed pulmonary defenses such as a patient with chronic bronchitis (more likely Klebsiella or Pseudomonas spps) or • Hospital acquired | ||
| Pathogenesis • Aspiration of organisms results in inflammation and necrosis of underlying parenchyma • Tends to scar if alveolar septae are destroyed, | ||
| Epidemiology • Common in hospitalized patients and contributes to the cause of death in moribund patients • Most common community acquired pneumonia as well | ||
| General Gross Description • Patchy distribution particularly around small airways • Nodular, elevated, firm, airless regions • Range from red to gray depending on age of the lesion • Can become confluent to mimic lobar pneumonia •Examples: | ||
| General Microscopic Description • Bronchocentric lesions • Neutrophils fill airway and surrounding alveoli • Parenchymal destruction depends on organism • Uninvolved parenchyma may contain acellular pink edema •Examples: | ||
| Clinical Correlation • Clinical course dependent on underlying disease processes • Patients present with fever, cough and purulent sputum | ||
| References • Cotran RS, Kumar V, Robbins SL: Robbins Pathologic Basis of Disease. 5th edition. Philadelphia, W.B. Saunders, 1994, pp. 694-698. Please be patient during transfer. Medline will open in a new window. To return, close the Medline Window Bronchopneumonia
| Synopsis by: Melinda Sanders M.D. (T28000M40000)[122]
| |
|
|
|
|
|
|